Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort
11.7 % of patients historically labeled as NAFLD met criteria for MetALD or ALD, underscoring the importance of updated nomenclature. High fibrosis prevalence and ALD-related mortality highlight the need for early screening, precise alcohol assessment, and multidisciplinary care to improve outcomes.
Authors
- Amani Bajunayd
- Luis Antonio Díaz (ORCID: https://orcid.org/0000-0002-8540-4930)
- Francisco Javier Idalsoaga (ORCID: https://orcid.org/0000-0001-5607-0698)
- Julie Kim (ORCID: https://orcid.org/0000-0001-9834-8213)
- Juan Pablo Arab (ORCID: https://orcid.org/0000-0002-8561-396X)
- Rokhsana Mortuza (ORCID: https://orcid.org/0000-0001-9586-9371)
- Mohammad Qasim Khan (ORCID: https://orcid.org/0000-0002-3457-7858)
- Adrienne Abaya
- Yousef Almahanna
- Yi Nong Song
- Ahmed Almohsen
Institutions
- Western University (CA)
- Pontificia Universidad Católica de Chile (CL)
- London Health Sciences Centre (CA)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.aohep.2025.102166
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00